Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah M Dry

Showing results (101-110 of 144) with videos related to

Pageof 15
Sort By:
Oncotarget|October 4, 2017
A novel anionic-phosphate-platinum complex effectively targets an undifferentiated pleomorphic sarcoma better than cisplatinum and doxorubicin in a patient-derived orthotopic xenograft (PDOX)Kentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Tissue & Cell|May 29, 2019
Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Oncotarget|February 9, 2018
Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse modelsKei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
The American Journal of Surgical Pathology|October 22, 2013
Appropriate use of special stains for identifying Helicobacter pylori: Recommendations from the Rodger C. Haggitt Gastrointestinal Pathology SocietyKenneth P Batts, Scott Ketover, Sanjay Kakar, et al.
Tissue & Cell|August 1, 2018
Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse modelTasuku Kiyuna, Takashi Murakami, Yasunori Tome, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2009
PTEN dosage is essential for neurofibroma development and malignant transformationCaroline Gregorian, Jonathan Nakashima, Sarah M Dry, et al.
Anticancer Research|May 6, 2020
Recombinant Methioninase Combined With Tumor-targeting <i>Salmonella typhimurium</i> A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated LiposarcomaKentaro Igarashi, Kei Kawaguchi, Ming Zhao, et al.
Medical Physics|April 28, 2021
Prediction of soft tissue sarcoma response to radiotherapy using longitudinal diffusion MRI and a deep neural network with generative adversarial network-based data augmentationYu Gao, Vahid Ghodrati, Anusha Kalbasi, et al.
BMC Cancer|August 22, 2018
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse modelTasuku Kiyuna, Yasunori Tome, Takashi Murakami, et al.
Biopreservation and Biobanking|February 3, 2018
The College of American Pathologists Biorepository Accreditation Program: Results from the First 5 YearsShannon J McCall, Philip A Branton, Victoria M Blanc, et al.
Pageof 15

Showing results (101-110 of 144) with videos related to

Sort By:
Pageof 15
Oncotarget|October 4, 2017
A novel anionic-phosphate-platinum complex effectively targets an undifferentiated pleomorphic sarcoma better than cisplatinum and doxorubicin in a patient-derived orthotopic xenograft (PDOX)Kentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Tissue & Cell|May 29, 2019
Pazopanib regresses a doxorubicin-resistant synovial sarcoma in a patient-derived orthotopic xenograft mouse modelKentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, et al.
Oncotarget|February 9, 2018
Recombinant methioninase (rMETase) is an effective therapeutic for BRAF-V600E-negative as well as -positive melanoma in patient-derived orthotopic xenograft (PDOX) mouse modelsKei Kawaguchi, Kentaro Igarashi, Shukuan Li, et al.
The American Journal of Surgical Pathology|October 22, 2013
Appropriate use of special stains for identifying Helicobacter pylori: Recommendations from the Rodger C. Haggitt Gastrointestinal Pathology SocietyKenneth P Batts, Scott Ketover, Sanjay Kakar, et al.
Tissue & Cell|August 1, 2018
Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse modelTasuku Kiyuna, Takashi Murakami, Yasunori Tome, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2009
PTEN dosage is essential for neurofibroma development and malignant transformationCaroline Gregorian, Jonathan Nakashima, Sarah M Dry, et al.
Anticancer Research|May 6, 2020
Recombinant Methioninase Combined With Tumor-targeting <i>Salmonella typhimurium</i> A1-R Induced Regression in a PDOX Mouse Model of Doxorubicin-resistant Dedifferentiated LiposarcomaKentaro Igarashi, Kei Kawaguchi, Ming Zhao, et al.
Medical Physics|April 28, 2021
Prediction of soft tissue sarcoma response to radiotherapy using longitudinal diffusion MRI and a deep neural network with generative adversarial network-based data augmentationYu Gao, Vahid Ghodrati, Anusha Kalbasi, et al.
BMC Cancer|August 22, 2018
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse modelTasuku Kiyuna, Yasunori Tome, Takashi Murakami, et al.
Biopreservation and Biobanking|February 3, 2018
The College of American Pathologists Biorepository Accreditation Program: Results from the First 5 YearsShannon J McCall, Philip A Branton, Victoria M Blanc, et al.
Pageof 15